Interleukin-1 Receptor Antagonist

This page covers all Interleukin-1 Receptor Antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Interleukin-1 receptor, type I, IL-1 receptor type I.

Targets

Interleukin-1 receptor, type I · IL-1 receptor type I

Marketed (2)

• Anakinra · Biovitrum Ab · Immunology
• Kineret® (Anakinra) · Amgen · Immunology
  Anakinra is a recombinant interleukin-1 receptor antagonist that blocks IL-1 signaling to reduce inflammation.

Patent intelligence

• interleukin 1 receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates